Search - tctmd.com

Displaying 801 - 820 of 1123

Sort: Relevancy | Date

News Daily News

Good Outcomes of Novel Bioresorbable-Polymer SES Persist at 2 Years

Yael L. Maxwell

October 02, 2015

News Industry News

REVA Completes Clinical Enrollment Milestone

October 01, 2015

News Industry News

Medinol Completes Enrollment In Randomized, Multicenter, Pivotal Study Of eDES™ Coronary Stent System

September 23, 2015

Presentation Aortovascular 2015

Scaffolds, Injectables, Tacks, Smashers, etc: Future endovascular therapies

Presenter: William A. Gray

September 18, 2015

News Industry News

Ventrix Initiates Clinical Trial of VentriGel™

September 17, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Conference News ESC 2015

PRESERVATION I: Bioabsorbable Cardiac Matrix Does Not Benefit STEMI Patients

Yael L. Maxwell

September 02, 2015

News Conference News ESC 2015

ABSORB Trials Pit BRS Against Second-Generation DES

Caitlin E. Cox

September 02, 2015

News Conference News ESC 2015

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

Caitlin E. Cox

September 02, 2015

Presentation ESC 2015

12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs_ metallic DES in de novo native coronary artery lesions

Presenter: Takeshi Kimura

September 01, 2015

News Industry News

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

September 01, 2015

News Daily News

登记研究表明 Absorb BVS 治疗所有糖尿病患者的效果与 DES 相当

August 27, 2015

News Daily News

Un Estudio de Registro Sugiere que AVB y SLF son Iguales en Pacientes Diabéticos No Seleccionados

August 27, 2015

News Daily News

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

August 27, 2015

Presentation

Implantation of Everolimus-Eluting Bioresorbable Scaffolds in a Diabetic All-Comers Population

Presenter: Jens Wiebe

August 26, 2015

News Industry News

Boston Scientific Initiates Study Evaluating New Fully Resorbable Scaffold Technology

July 20, 2015

News Daily News

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

L.A. McKeown

July 01, 2015

News Industry News

U.S. to vie with India for top bioabsorbable stent market after FDA approval

June 25, 2015

News Industry News

CorPath® System Robotically Deployed Bioresorbable Vascular Scaffold During Live Broadcast of a Complex Coronary Intervention at 2015 C3 Conference

June 18, 2015

News Daily News

La Anchura del Filamento de los BRS se asocia a Más IM Perioperatorios

June 02, 2015

Advertisement

Good Outcomes of Novel Bioresorbable-Polymer SES Persist at 2 Years

REVA Completes Clinical Enrollment Milestone

Medinol Completes Enrollment In Randomized, Multicenter, Pivotal Study Of eDES™ Coronary Stent System

Scaffolds, Injectables, Tacks, Smashers, etc: Future endovascular therapies

Ventrix Initiates Clinical Trial of VentriGel™

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

PRESERVATION I: Bioabsorbable Cardiac Matrix Does Not Benefit STEMI Patients

ABSORB Trials Pit BRS Against Second-Generation DES

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs_ metallic DES in de novo native coronary artery lesions

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

登记研究表明 Absorb BVS 治疗所有糖尿病患者的效果与 DES 相当

Un Estudio de Registro Sugiere que AVB y SLF son Iguales en Pacientes Diabéticos No Seleccionados

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

Implantation of Everolimus-Eluting Bioresorbable Scaffolds in a Diabetic All-Comers Population

Boston Scientific Initiates Study Evaluating New Fully Resorbable Scaffold Technology

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

U.S. to vie with India for top bioabsorbable stent market after FDA approval

CorPath® System Robotically Deployed Bioresorbable Vascular Scaffold During Live Broadcast of a Complex Coronary Intervention at 2015 C3 Conference

La Anchura del Filamento de los BRS se asocia a Más IM Perioperatorios

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content